Ontology highlight
ABSTRACT:
SUBMITTER: Acar O
PROVIDER: S-EPMC3678432 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
TheScientificWorldJournal 20130527
The effective treatment of castrate-resistant prostate cancer (CRPC) has proven to be very challenging. Until recently, docetaxel was the only therapeutic demonstrated to extend overall patient survival. Yet recently, a considerable number of new therapeutics have been approved to treat CRPC patients. These remarkable advances now give new tools for the therapeutic management of late-stage prostate cancer. In this review, we will examine mechanistic and clinical data of several newly approved th ...[more]